The more solvent you add, the lower the concentration per milliliter, while less solvent results in a higher concentration
It was the first peptide of its kind, described by Cyril Bowers in 1984, and it is the parent compound behind GHRP-2, hexarelin, and ipamorelin
For patients with less severe cognitive problems, specifically mild cognitive impairment or early-stage Alzheimer's disease, the clinical trial evidence is slightly more positive but also less reliable [11].
Therefore, when testing antidepressants in WKY rats, incorporating behavioral paradigms not reliant on locomotor activity in addition to the FST may provide a more comprehensive evaluation of the depressive phenotype in WKY rats
But remember all supplements are not created equal